Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia

In the absence of randomized controlled trials comparing tisagenlecleucel vs. standard of care (SOC) in pediatric and young adult patients with relapsed or refractory acute lymphoblastic leukemia (r/r ALL), the objective was to compare the efficacy of tisagenlecleucel with historical controls from m...

Descripción completa

Detalles Bibliográficos
Autores principales: v. Stackelberg, Arend, Jäschke, Katja, Jousseaume, Etienne, Templin, Corinna, Jeratsch, Ulli, Kosmides, Daniela, Steffen, Ingo, Gökbuget, Nicola, Peters, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681894/
https://www.ncbi.nlm.nih.gov/pubmed/37880478
http://dx.doi.org/10.1038/s41375-023-02042-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681894/
https://www.ncbi.nlm.nih.gov/pubmed/37880478
http://dx.doi.org/10.1038/s41375-023-02042-4

Ejemplares similares